Hansa Biopharma to Present at the Cowen 39th Annual Health Care Conference
- Wednesday, March 6, 2019, 2:26
- Environment
- Add a comment
LUND, Sweden, March 6, 2019 /PRNewswire/ — Hansa Biopharma AB (NASDAQ Stockholm: HNSA), the leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, announced today that Søren Tulstrup, President and CEO of Hansa Biopharma, will present at the Cowen 39th Annual Health …
Source: https://www.prnewswire.com:443/news-releases/hansa-biopharma-to-present-at-the-cowen-39th-annual-health-care-conference-300807520.html
About the Author
adminasapcorp has written 38990 stories on this site.